how effective is oral glp 1 New GLP-1 drug delivers up to 12% weight loss in 36 weeks VisualAbstract: Daily Oral GLP-1 Receptor

CrossRef Global, regional and national burden and trends of non-alcoholic fatty liver disease in women of reproductive age from 1990 to 2021: Insights from the Global burden of disease study 2021 Yi Yu, Chunxia Zhang, Zirong Liang, Xiang Wang, Jun Wang, Feihu Bai, Dekui Zhang, Yonggang Tian Indian Journal of Gastroenterology .2026;[Epub] CrossRef A CostUtility Analysis of Two-Stage Screening Strategies Based on Waist-to-Height Ratio for Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in China Yunfei Liu, Tianyu Huang, Jiajia Dang, Shan Cai, Jiaxin Li, Ruolan Yang, Jiabin Zhang, Kaiheng Zhu, Ziyue Sun, Yang Yang, Yajie Wang, Bo Xi, Yi Song Healthcare .2026

Considered the newest GLP-1based therapy on the horizon, retatrutide is a triple receptor agonist that targets GLP-1, GIP, and glucagon receptors

The Maximus weight loss protocol offers GLP-1 agonists from compounding pharmacies

Estrogen has anti-inflammatory effects, so its decline can increase inflammatory markers

Osteoarthritis and intervertebral disc degeneration: quite different, quite similar